ArticleMolecules (Basel, Switzerland)2022

Erdafitinib Inhibits Tumorigenesis of Human Lung Adenocarcinoma A549 by Inducing S-Phase Cell-Cycle Arrest as a CDK2 Inhibitor.

Xinmin Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.